| David E Kemp, MD | |
|
4440 W 95th St, Oak Lawn, IL 60453-2600 | |
| (708) 684-7482 | |
| Not Available |
| Full Name | David E Kemp |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 22 Years |
| Location | 4440 W 95th St, Oak Lawn, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710061486 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 35088017 (Ohio) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 36111724 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Christ Hospital & Medical Center | Oak lawn, IL | Hospital |
| Advocate Trinity Hospital | Chicago, IL | Hospital |
| Advocate Condell Medical Center | Libertyville, IL | Hospital |
| Advocate Sherman Hospital | Elgin, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beth Ledvora Md Sc | 4587898754 | 6 |
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
Researchers from the University of Cambridge and the Pirbright Institute in the UK have identified key genetic changes in SARS-CoV-2 that may be responsible for the virus's jump from bats to humans. The team also determined which animals contain cellular receptors that allow the virus to enter cells more effectively, zoning in on potential animals that acted as an intermediary host in facilitating SARS-CoV-2's zoonosis.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
On the advent of the 2017 Head and Neck Cancer Awareness Week, the European Cancer Patient Coalition invited patients and policy makers to gather at the European Parliament to promote better quality of life for cancer patients and survivors as part of the Make Sense Campaign.
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
Cytokinetics has announced the initiation of a Phase II clinical trials program evaluating CK-1827452, a novel cardiac myosin activator for the potential treatment of patients with either acutely decompensated or chronic heart failure.
› Verified 7 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Researchers from the University of Cambridge and the Pirbright Institute in the UK have identified key genetic changes in SARS-CoV-2 that may be responsible for the virus's jump from bats to humans. The team also determined which animals contain cellular receptors that allow the virus to enter cells more effectively, zoning in on potential animals that acted as an intermediary host in facilitating SARS-CoV-2's zoonosis.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
On the advent of the 2017 Head and Neck Cancer Awareness Week, the European Cancer Patient Coalition invited patients and policy makers to gather at the European Parliament to promote better quality of life for cancer patients and survivors as part of the Make Sense Campaign.
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
Cytokinetics has announced the initiation of a Phase II clinical trials program evaluating CK-1827452, a novel cardiac myosin activator for the potential treatment of patients with either acutely decompensated or chronic heart failure.
› Verified 7 days ago
| Entity Name | Beth Ledvora Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003256462 PECOS PAC ID: 4587898754 Enrollment ID: O20131002000408 |
News Archive
Researchers from the University of Cambridge and the Pirbright Institute in the UK have identified key genetic changes in SARS-CoV-2 that may be responsible for the virus's jump from bats to humans. The team also determined which animals contain cellular receptors that allow the virus to enter cells more effectively, zoning in on potential animals that acted as an intermediary host in facilitating SARS-CoV-2's zoonosis.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
On the advent of the 2017 Head and Neck Cancer Awareness Week, the European Cancer Patient Coalition invited patients and policy makers to gather at the European Parliament to promote better quality of life for cancer patients and survivors as part of the Make Sense Campaign.
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
Cytokinetics has announced the initiation of a Phase II clinical trials program evaluating CK-1827452, a novel cardiac myosin activator for the potential treatment of patients with either acutely decompensated or chronic heart failure.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David E Kemp, MD 29373 Network Pl, Chicago, IL 60673-1293 Ph: () - | David E Kemp, MD 4440 W 95th St, Oak Lawn, IL 60453-2600 Ph: (708) 684-7482 |
News Archive
Researchers from the University of Cambridge and the Pirbright Institute in the UK have identified key genetic changes in SARS-CoV-2 that may be responsible for the virus's jump from bats to humans. The team also determined which animals contain cellular receptors that allow the virus to enter cells more effectively, zoning in on potential animals that acted as an intermediary host in facilitating SARS-CoV-2's zoonosis.
While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.
On the advent of the 2017 Head and Neck Cancer Awareness Week, the European Cancer Patient Coalition invited patients and policy makers to gather at the European Parliament to promote better quality of life for cancer patients and survivors as part of the Make Sense Campaign.
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
Cytokinetics has announced the initiation of a Phase II clinical trials program evaluating CK-1827452, a novel cardiac myosin activator for the potential treatment of patients with either acutely decompensated or chronic heart failure.
› Verified 7 days ago
Dr. Paul A Dobransky, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-7482 | |
Dr. Utpal H Dhruve, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-7482 | |
Leah M Ustas, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-7482 | |
Phillip Bryce Jones, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 405-990-5460 | |
Jessica M Nicholson, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 95th St Ste 404, Oak Lawn, IL 60453 Phone: 708-684-3980 Fax: 708-684-3980 | |
Aliya Hafeez, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-7482 | |
Miss Rochelle Tayel Sweis, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-8000 |